Department of Rheumatology, University Medical Centre Ljubljana, Vodnikova cesta 62, 1000, Ljubljana, Slovenia.
Institute of Computational Biotechnology, Graz University of Technology, Petersgasse 14, 8010, Graz, Austria.
Clin Rheumatol. 2019 Feb;38(2):307-316. doi: 10.1007/s10067-018-4231-y. Epub 2018 Aug 1.
Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.
巨细胞动脉炎(GCA)是一种发生于 50 岁以上人群的系统性血管炎,其特征为头痛、视觉障碍、头皮痛、下颌跛行、肢体动脉受损以及全身炎症等症状。GCA 的诊断通过阳性颞动脉活检(TAB)或影像学方式加以确认。显著的急性期炎症反应是该病的主要特征,主要影响大、中动脉,导致动脉管腔狭窄或闭塞。目前,尚无针对 GCA 的特异性组织标志物。为数不多的报告表明,表观遗传学在 GCA 中具有重要作用。本系统综述报告了与非 GCA 患者相比,GCA 患者 TAB 中使用 qPCR 检测到的候选生物标志物有显著变化。